BHCM
CVAC

Brevan Howard Capital Management’s CureVac CVAC Stock Holding History

Brevan Howard Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,738
Closed -$68.9K – 1117
2024
Q1 		$68.9K Buy
22,738
+8,633
+61% +$30.3K ﹤0.01% 923
2023
Q4 		$59.4K Buy
+14,105
New +$76.5K ﹤0.01% 990

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's CVAC Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of CureVac (CVAC) in Q2 2024, closing a stake of 22,738 shares — an estimated $68.9K sold.

Brevan Howard Capital Management first reported a position in CVAC in Q4 2023 and held it in 2 quarters. The position peaked at $68.9K in Q1 2024. 87 funds tracked by Wall St. Rank hold CVAC as of Q2 2024.

  • Brevan Howard Capital Management reported no remaining CureVac position as of Q2 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 22,738 CureVac shares in Q2 2024, an estimated $68.9K.
  • Brevan Howard Capital Management first reported a position in CureVac in Q4 2023 and held it in 2 quarters.
  • Brevan Howard Capital Management's CureVac position peaked at $68.9K in Q1 2024.
  • 87 funds tracked by Wall St. Rank held CureVac as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.